- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06070363
Effectiveness of Manual Acupuncture and Standard Therapy Compared to Standard Therapy in Gynecological Cancer Pain
Study Overview
Status
Intervention / Treatment
Detailed Description
The main outcome is to analyze the effectiveness of manual acupuncture therapy (LI4,PC6, LR3,ST36, and SP6 plus standard therapy on pain intensity (VAS score), changes in analgesic dose, and quality of life (QLQ C-30 EORTC score) in patients with gynecological cancer pain compared to standard therapy alone.
The patient will attempt 3-day manual acupuncture therapy with seven days follow up Patient will receive acupuncture therapy daily for 3 days, for 15 minute each day.
The research design in this study was a single-blinded randomized control clinical trial. With outcome measures for
With Subject criteria:
Inclusion Criteria
- The patient is diagnosed with gynecological cancer
- Women over 18 years to 65 years
Subjects experiencing cancer pain, with VAS ≥4, namely pain caused by:
- tumors,
- before or during a therapeutic process (radiation therapy, chemotherapy, or post-surgery)
- side effect or the result of toxicity of cancer treatment
- Supportive therapy (palliative therapy, painkillers, antidepressants)
- Willing to participate in this study and sign an informed consent Exclusion Criteria
1) The patient has a medical emergency / hemodynamically unstable 2) Patients with contraindications for manual acupuncture procedures such as wounds and infections at the point where the puncture will be performed, patients allergic to stainless steel62 3) Uncooperative patients (patients with negative and aggressive affect, who do not allow acupuncture therapy) 4) There is a tumor in the area that will be stabbed and stimulated in the pregnant woman's abdomen, close to the heart, or around the carotid sinus, lymphedema, needle insertion into the prosthesis 5) Patients with heart rhythm disorders 6) The patient uses a pacemaker 7) Patients with disorders of the auricle such as eczema, external otitis, and psoriasis 8) Patients with blood clotting disorders, with platelets <50,000, and in neutropenic conditions with neutrophils <1000
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
DKI Jakarta
-
Jakarta, DKI Jakarta, Indonesia, 14250
- Suryamin Hung
-
-
Dki Jakarta
-
Jakarta, Dki Jakarta, Indonesia, 10430
- Fatmawati Hospital
-
Jakarta, Dki Jakarta, Indonesia, 13230
- Persahabatan Hospital
-
Jakarta Pusat, Dki Jakarta, Indonesia, 10430
- Cipto Mangunkusumo Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female 18 to 65 years old
- Gynecocal cancer with pain ≥ 4 acording Visual Analog scale and receive analgetic medicine
The pain cause by
- direct from cancer
- Treatment proces surgery, radiotherapy, chemotherapy, paliatif treatment, supportive treatment
- Adverse reaction form treatment and intoxication
Exclusion Criteria:
- emergency case patient with hemodynamic instable
- patient with uncooperative behavior because ith serious psychological disorders, no currently undergoing psychiatric treatment, aggressive behavior, that not allowed for acupuncture.
- Patients with blood clotting disorders, with platelets <50.000 and in neutropenic condition with <1000 neutrophils.
The patient has an allergy to stainless steel acupuncture needles. Wounds at the acupuncture point puncture sites, skin infections in the ears. On patients with eczema on the ears, external otitis or psoriasis.
There is a tumor in the area that will be stabbed and stimulated in the stomach pregnant women, close to the heart, or in the area of the carotid sinus lymphedema, insertion into the prosthesis.
Patients with heart rhythm disorders. The patient uses a pace maker.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
The Patient are cancer patient that experience cancer pain that only receive analgetic drug treatment according to WHO Stepledder of Pain
|
|
|
Experimental: Manual acupuncture and standard Therapy
The Patient are cancer patient that experience cancer paint that receive analgetic drug treatement according WHO stepledder of pain and receive manual acupuncture
|
Acupuncture Needle Insertion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain severity with Visual Analog Scale
Time Frame: Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
|
Visual Analog Scale (VAS) that score 0 is no pain to 100 the worse pain A higher scale means worse outcomes
|
Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life with European Organisation for Research and Treatment of Cancer Quality of Life C30
Time Frame: before treatment and 7 day after treatment
|
European Organisation for Research and Treatment of Cancer Quality of Life C30, that include two item of review functional scale and the global health scale both scale the higher the score the outcome will be better
|
before treatment and 7 day after treatment
|
|
Analgetic Usage in dosage and frequency
Time Frame: Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
|
Description of analagetic dosage and frequency during observation that will be describe as medicine category opioid non opioid, dosage and frequency
|
Before treatment, After treatment in day 1, day 2, day 3, day 5 and day 7
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Suryamin Suryamin, Indonesia University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-06-1047
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.